Publication: Association and prognostic significance of the functional-1562C/T polymorphism in the promoter region of MMP-9 in Turkish patients with gastric cancer
dc.contributor.author | Avcı, Nilüfer | |
dc.contributor.author | Çubukçu, Erdem | |
dc.contributor.author | Ölmez, Ömer Fatih | |
dc.contributor.buuauthor | Türe, Mehmet | |
dc.contributor.buuauthor | Deligönül, Adem | |
dc.contributor.buuauthor | Şahintürk, Serdar | |
dc.contributor.buuauthor | Topak, Ali | |
dc.contributor.buuauthor | Kurt, Ender | |
dc.contributor.buuauthor | Evrensel, Türkkan | |
dc.contributor.buuauthor | Şahin, Ahmet Bilgehan | |
dc.contributor.buuauthor | Yakut, Tahsin | |
dc.contributor.department | Tıp Fakültesi | |
dc.contributor.department | Tıbbi Genetik Ana Bilim Dalı | |
dc.contributor.orcid | 0000-0002-7612-0055 | tr_TR |
dc.contributor.orcid | 0000-0002-9732-5340 | tr_TR |
dc.contributor.orcid | 0000-0002-7846-0870 | tr_TR |
dc.contributor.researcherid | ECY-8582-2022 | tr_TR |
dc.contributor.researcherid | ESM-4544-2022 | tr_TR |
dc.contributor.researcherid | ACQ-9887-2022 | tr_TR |
dc.contributor.researcherid | HOV-5404-2023 | tr_TR |
dc.contributor.researcherid | DAS-3088-2022 | tr_TR |
dc.contributor.researcherid | AAJ-1027-2021 | tr_TR |
dc.contributor.researcherid | AAM-4927-2020 | tr_TR |
dc.contributor.researcherid | GIS-1493-2022 | tr_TR |
dc.contributor.scopusid | 6602186133 | tr_TR |
dc.contributor.scopusid | 37088030300 | tr_TR |
dc.contributor.scopusid | 57214054591 | tr_TR |
dc.contributor.scopusid | 55313334700 | tr_TR |
dc.contributor.scopusid | 7006207332 | tr_TR |
dc.contributor.scopusid | 6603942124 | tr_TR |
dc.contributor.scopusid | 57188809248 | tr_TR |
dc.contributor.scopusid | 6602802424 | tr_TR |
dc.date.accessioned | 2024-03-18T11:23:42Z | |
dc.date.available | 2024-03-18T11:23:42Z | |
dc.date.issued | 2015-09-28 | |
dc.description.abstract | Matrix metalloproteinases (MMPs) are a group of zinc-dependent peptidases that participate in matrix turnover in solid malignancies. The aim of this study was twofold. First, we sought to investigate under a case-control design the association between the functional -1562C/T polymorphism in the promoter region of MMP-9 and gastric cancer (GC) in a Turkish sample. Second, we examined its prognostic significance in GC patients. A total of 144 subjects were enrolled in the case-control study (79 GC cases and 65 controls). Overall survival (OS) and progression-free survival (PFS) served as the main outcome measures in the longitudinal study. The MMP-9 -1562C/T polymorphism was genotyped using a polymerase chain reaction-restriction fragment length polymorphism method. The odds ratio (OR) of GC for the CC genotype relative to the CT+TT genotypes was not significant (OR = 0.89, 95 % confidence interval [CI] = 0.44-1.82, P = 0.75). These results did not change after allowance for age and sex in multivariable regression analysis (OR = 0.81, 95 % CI = 0.40-1.94, P = 0.84). When the MMP-9 -1562C/T polymorphism was analyzed among GC patients in relation to OS and PFS, we found no significant differences between subjects with the CC and CT+TT genotypes. In conclusion, the results of our study did not point toward a major role of the MMP-9 -1562C/T polymorphism in the pathogenesis and clinical course of GC in Turkish subjects. | en_US |
dc.identifier.citation | Avcı, N. vd. (2015). "Association and prognostic significance of the functional-1562C/T polymorphism in the promoter region of MMP-9 in Turkish patients with gastric cancer". Pathology and Oncology Research, 21(4), 1243-1247. | en_US |
dc.identifier.doi | https://doi.org/10.1007/s12253-015-9950-7 | |
dc.identifier.endpage | 1247 | tr_TR |
dc.identifier.issn | 1219-4956 | |
dc.identifier.issn | 1532-2807 | |
dc.identifier.issue | 4 | tr_TR |
dc.identifier.pubmed | 26156886 | tr_TR |
dc.identifier.scopus | 2-s2.0-84940449521 | tr_TR |
dc.identifier.startpage | 1243 | tr_TR |
dc.identifier.uri | https://link.springer.com/article/10.1007/s12253-015-9950-7 | |
dc.identifier.uri | https://hdl.handle.net/11452/40458 | |
dc.identifier.volume | 21 | tr_TR |
dc.identifier.wos | 000360385400050 | |
dc.indexed.pubmed | PubMed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Frontiers Media | en_US |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.relation.journal | Pathology and Oncology Research | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Oncology | tr_TR |
dc.subject | Pathology | tr_TR |
dc.subject | Gastric cancer | tr_TR |
dc.subject | Matrix metalloproteinases | tr_TR |
dc.subject | Polymorphism | tr_TR |
dc.subject | Association study | tr_TR |
dc.subject | Prognosis | tr_TR |
dc.subject | Matrix metalloproteinases | tr_TR |
dc.subject | Matrix-metalloproteinase-9 | tr_TR |
dc.subject | Epidemiology | tr_TR |
dc.subject | Gene | tr_TR |
dc.subject | Metaanalysis | tr_TR |
dc.subject | Risk | tr_TR |
dc.subject.emtree | Gelatinase B | tr_TR |
dc.subject.emtree | Adult | tr_TR |
dc.subject.emtree | Article | tr_TR |
dc.subject.emtree | Cancer prognosis | tr_TR |
dc.subject.emtree | Case control study | tr_TR |
dc.subject.emtree | Controlled study | tr_TR |
dc.subject.emtree | Female | tr_TR |
dc.subject.emtree | Genetic association | en_US |
dc.subject.emtree | Genotype | en_US |
dc.subject.emtree | Genotyping technique | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Longitudinal study | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | MMP 9 gene | en_US |
dc.subject.emtree | Oncogene | en_US |
dc.subject.emtree | Overall survival | en_US |
dc.subject.emtree | Polymerase chain reaction | en_US |
dc.subject.emtree | Progression free survival | en_US |
dc.subject.emtree | Promoter region | en_US |
dc.subject.emtree | Restriction fragment length polymorphism | en_US |
dc.subject.emtree | Single nucleotide polymorphism | en_US |
dc.subject.emtree | Stomach cancer | en_US |
dc.subject.emtree | Turk (people) | en_US |
dc.subject.emtree | Allele | en_US |
dc.subject.emtree | Disease free survival | en_US |
dc.subject.emtree | Gene frequency | en_US |
dc.subject.emtree | Genetics | en_US |
dc.subject.emtree | Middle aged | en_US |
dc.subject.emtree | Pathology | en_US |
dc.subject.emtree | Prognosis | en_US |
dc.subject.emtree | Promoter region | en_US |
dc.subject.emtree | Single nucleotide polymorphism | en_US |
dc.subject.emtree | Stomach tumor | en_US |
dc.subject.mesh | Alleles | en_US |
dc.subject.mesh | Case-control studies | en_US |
dc.subject.mesh | Disease-free survival | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Gene frequency | en_US |
dc.subject.mesh | Genotype | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Longitudinal studies | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Matrix metalloproteinase 9 | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Polymorphism, single nucleotide | en_US |
dc.subject.mesh | Prognosis | en_US |
dc.subject.mesh | Promoter regions, genetic | en_US |
dc.subject.mesh | Stomach neoplasms | en_US |
dc.subject.scopus | Interstitial collagenase; Gelatinase B; Matrix metalloproteinase 13 | en_US |
dc.subject.wos | Oncology | en_US |
dc.subject.wos | Pathology | en_US |
dc.title | Association and prognostic significance of the functional-1562C/T polymorphism in the promoter region of MMP-9 in Turkish patients with gastric cancer | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
local.contributor.department | Tıp Fakültesi/Nöroloji Ana Bilim Dalı | tr_TR |
local.contributor.department | Tıp Fakültesi/İç Hastalıkları Ana Bilim Dalı | tr_TR |
local.contributor.department | Tıp Fakültesi/Tıbbi Genetik Ana Bilim Dalı | tr_TR |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: